EnlightenBio-Logo-Reverse

Sema4 Announces Collaboration with Janssen on Optimizing Oncology Clinical Trials

Research alliance will leverage advanced data analytics and genomic testing to improve recruitment of patients in oncology clinical trials STAMFORD, CT — September 29, 2020 — Sema4, a patient-centered health...read more

Seven Bridges Advances Workflow Automation Capabilities to Make Complex Multi-Omic Analysis More Accessible to Broader Mix of Users

Seven Bridges RHEO™ Visual Interface Enables Biological Scientists and Developers to Work in a Single Environment at the Push of a Button BOSTON, September 23, 2020—Seven Bridges, the industry-leading bioinformatics...read more

Illumina to Acquire GRAIL to Launch New Era of Cancer Detection

Accelerates Commercialization and Adoption of Transformative Multi-Cancer Screening Test with Potential to Detect More Cancers Earlier and Enable Better Outcomes Adds Multi-Disciplinary Team and Capabilities Harnessing...read more

EnlightenBio-Logo-Reverse

Brigitte Ganter

Sema4 Announces Collaboration with Janssen on Optimizing Oncology Clinical Trials

Illumina to Acquire GRAIL to Launch New Era of Cancer Detection

ADVERTISEMENT

Recent posts

Gene Editing Revamped with CRISPR Prime Editor – Result Is A High Efficiency, More Precise Gene Editor With Versatile Editing Capabilities And Lower Off-Target Effects

An interview with Michael Snyder, Stanford W. Ascherman Professor and Chair, Department of Genetics & Director, Center for Genomics and Personalized Medicine

Nebion Provides Curated Omics Data Combined with Innovative Visualizations for Target Discovery, Indication Finding, and Drug Safety Assessment

Mike Pellini, Section 32: “I hope we will find a way where the payers and the healthcare industry will work much more closely together to generate the data that will ultimately be useful in answering difficult, cost-based decisions.”

Othram Aims to Overcome DNA Sequencing Challenges to Solve Forensic Crime Cases

Immunotherapy and the Basis of Neoantigen Biology: Part I Neoantigens

Follow Me

Most popular

Sema4 Announces Collaboration with Janssen on Optimizing Oncology Clinical Trials

Illumina to Acquire GRAIL to Launch New Era of Cancer Detection

Tempus and LabCorp Announce Collaboration to Accelerate Clinical Trial Patient Participation

NanoString Launches Whole Transcriptome Atlas under GeoMx Technology Access Program and Names First GeoMx Premier Access Sites

GRAIL Announces Filing of Registration Statement for Proposed Initial Public Offering

ClinSpec Dx receive £2.4m funding boost

Invitae launches multi-site study to evaluate the role of testing guidelines in ensuring access to genetic information for men with prostate cancer

Illumina Collaborates With 54gene in the Creation of a World-Class Genomics Facility in Nigeria

Freenome Closes $270 Million Series C Financing to Advance Novel Multiomics Blood Testing Platform for Early Cancer Detection

Bionano Genomics Acquires Diagnostics Services Provider Lineagen, Inc. to Accelerate Clinical Adoption of Saphyr for Digital Cytogenetics

Biofidelity raises $12m in Series A financing to accelerate launch of disruptive cancer diagnostic technology

Most discussed

Genohm Aims to Hit the Sweet Spot With a Customizable SLIMS + ELN Solution for Lab Information Management

Genomenon’s Automated Genomic Search Engine Mastermind Illuminates Current Trends in Genomic Literature – A Look at the Top Cited Variants Across the Scientific Literature

Just Released – Our New Clinical NGS Process Report

The JP Morgan Healthcare Conference from Afar

The Life of a Genetic Counselor: Providing Patient Education, Navigating Insurance, and Challenges in Choosing Tests

Immunotherapy and the Basis of Neoantigen Biology: Part I Neoantigens

Review of Emerging 2018 Genomic Variants – a Genomenon Research Report

PMWC 2016 Silicon Valley: Scalable Clinical Data Interpretation The Biggest Bottleneck

Nebula Genomics’ Goal Is To Make The Value of Genome Sequencing a Reality

ACMG 2014 headlines included rethinking diagnostics, incidental findings, & variant interpretation

EnlightenBio-Logo-Reverse

Brigitte Ganter

You may also like

ADVERTISEMENT

Recent posts

Follow Me

Most popular

Most discussed